Actively Recruiting

Age: 18Years +
All Genders
NCT04028687

MDR - PMCF Study for Taperloc Complete Stems

Led by Zimmer Biomet · Updated on 2025-03-11

820

Participants Needed

3

Research Sites

626 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The objective of this consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the Taperloc Complete stems when used for primary or revision total hip arthroplasty (implants) at 1,3,5,7 and 10-year follow-up\*. Since Taperloc Complete was introduced to the EU in 2010, all available retrospective data will be collected from each patient and a prospective aspect to the study will be necessary to reach the 10-year time point.

CONDITIONS

Official Title

MDR - PMCF Study for Taperloc Complete Stems

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient must be 18 years of age or older and skeletally mature
  • Patient must be willing and able to sign IRB approved informed consent
  • Patient must have undergone primary or revision hip arthroplasty with the Taperloc Complete stem for approved indications including non-inflammatory degenerative joint disease, osteoarthritis, avascular necrosis, rheumatoid arthritis, correction of functional deformity, treatment of non-union, femoral neck fracture, and certain trochanteric fractures
Not Eligible

You will not qualify if you...

  • Off-label use of the implant
  • Presence of infection, sepsis, or osteomyelitis
  • Uncooperative patients or those with neurologic disorders unable to follow directions
  • Osteoporosis or metabolic disorders impairing bone formation
  • Osteomalacia
  • Distant infections that may spread to the implant site
  • Rapid joint destruction or marked bone loss visible on X-ray
  • Vascular insufficiency, muscular atrophy, or neuromuscular disease
  • Known pregnancy or nursing
  • Prisoner status
  • Known alcohol or drug abuse
  • Psychiatric illness or cognitive deficits preventing proper informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Orthopaedic Institute of Henderson

Henderson, Nevada, United States, 89052

Withdrawn

2

Texas Health Physicians Group

Plano, Texas, United States, 75243

Actively Recruiting

3

Proliance Orthopaedics and Sports Medicine

Bellevue, Washington, United States, 98004

Withdrawn

Loading map...

Research Team

M

Megan McKinnie

CONTACT

L

Lynsey Boyle

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here